Ethical, legal and social implications of human genome studies in radiation research: a workshop report for studies on atomic bomb survivors at the Radiation Effects Research Foundation.

atomic bomb survivors community engagement genome sequencing (GS) genome study ethical, legal and social implications (ELSI) human biosamples informed consent

Journal

Journal of radiation research
ISSN: 1349-9157
Titre abrégé: J Radiat Res
Pays: England
ID NLM: 0376611

Informations de publication

Date de publication:
10 Jul 2021
Historique:
received: 10 03 2021
revised: 19 04 2021
pubmed: 2 6 2021
medline: 24 12 2021
entrez: 1 6 2021
Statut: ppublish

Résumé

The Radiation Effects Research Foundation (RERF) is the primary organization in Japan dedicated to studying the health consequences of the Hiroshima and Nagasaki atomic bombings in World War II. In December 2020, RERF held a virtual international workshop on the ethical, legal and social implications (ELSI) of genome studies. In this workshop, the ELSI considerations of future human genome studies on radiation research including atomic bomb survivors and their families were discussed. Since genome sequencing (GS) is now practical and affordable, RERF now plans GS of parents/child trios to examine genetic effects of atomic bomb radiation. As such studies may engender some novel risks and benefits, ethics review and engagement with families (including consent) need to be considered. These include protection of individual privacy, use of samples from deceased prior participants, return of results to the participants, public sharing of genome data and advance science and social welfare. Specifically with regard to social welfare, the results of such studies may have implications for public and government decision-making regarding social benefits of victims and other important questions. Based on these broad-ranging discussions we have developed the following concepts to guide this work: "trust," "compromise" and "relationship building," inclusive of the concerned stakeholders, scientific aims and Japanese society at large. We conclude that in order to realize, establish and maintain these concepts, it is essential to put procedures into place to ensure the successful, consensus-based implementation of the RERF studies.

Identifiants

pubmed: 34059901
pii: 6290177
doi: 10.1093/jrr/rrab043
pmc: PMC8273803
doi:

Types de publication

Congress

Langues

eng

Sous-ensembles de citation

IM

Pagination

656-661

Subventions

Organisme : NHGRI NIH HHS
ID : HG004488
Pays : United States
Organisme : NHGRI NIH HHS
ID : P50 HG004488
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002319
Pays : United States
Organisme : NIH HHS
ID : UL1 TR002319
Pays : United States
Organisme : MEXT
ID : 20 K12179

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of The Japanese Radiation Research Society and Japanese Society for Radiation Oncology.

Références

Genet Med. 2013 Jul;15(7):565-74
pubmed: 23788249
Sci Rep. 2020 Jan 8;10(1):37
pubmed: 31913321
Am J Bioeth. 2017 Dec;17(12):3-11
pubmed: 29148951
J Radiat Res. 2006;47 Suppl B:B67-73
pubmed: 17019054
N Engl J Med. 2009 Jul 16;361(3):245-54
pubmed: 19605829
J Hum Genet. 2020 Mar;65(3):251-261
pubmed: 31873219
Science. 2021 May 14;372(6543):725-729
pubmed: 33888597
Med Care. 2018 Oct;56 Suppl 10 Suppl 1:S6-S8
pubmed: 30015725
Nat Commun. 2015 Mar 26;6:6684
pubmed: 25809527
Lancet Oncol. 2015 Oct;16(13):1275-6
pubmed: 26384239
J Epidemiol. 2018 Apr 5;28(4):162-169
pubmed: 29553058
PLoS One. 2015 Jul 17;10(7):e0132690
pubmed: 26186621

Auteurs

Asao Noda (A)

Department of Molecular Biosciences, Radiation Effects Research Foundation, Hiroshima 732-0815, Japan.

Kazuto Kato (K)

Department of Biomedical Ethics and Public Policy, Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan.

Chieko Tamura (C)

Division of Medical Information and Genetic Counseling, FMC Tokyo Clinic, Tokyo 102-0072, Japan.

Leslie G Biesecker (LG)

Center for Precision Health Research, National Human Genome Research Institute, Bethesda, MD 20892, USA.

Misa Imaizumi (M)

Department of Clinical Studies, Radiation Effects Research Foundation, Nagasaki 850-0013, Japan.

Yusuke Inoue (Y)

Department of Public Policy, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.

Gail E Henderson (GE)

Department of Social Medicine, and Center for Genomics and Society, University of North Carolina School of Medicine, Chapel Hill, NC 27599-7240, USA.

Benjamin Wilfond (B)

Treuman Katz Center for Pediatric Bioethics, Seattle Children's Hospital and Research Institute, Department of Pediatrics, Institute of Translational Health Sciences, University of Washington School of Medicine, Seattle, WA 98101, USA.

Kaori Muto (K)

Department of Public Policy, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.

Mariko Naito (M)

Department of Oral Epidemiology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8553, Japan.

Junji Kayukawa (J)

Department of Social System Design, Eikei University of Hiroshima, Hiroshima 730-0016, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH